Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells

Previous studies showed that either histone deacetylase (HDAC) inhibitors or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can induce apoptosis in tumor cells including breast cancer. However, the underling mechanisms of combining HDAC inhibitors with TRAIL in the treatment of brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Weiqiang, Feng, Xiuyan, Han Han, Guo, Shanchun, Wang, Guangdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904277/
https://www.ncbi.nlm.nih.gov/pubmed/27292433
http://dx.doi.org/10.1038/srep28004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904277/
https://www.ncbi.nlm.nih.gov/pubmed/27292433
http://dx.doi.org/10.1038/srep28004

Ejemplares similares